Summary

Canada faces a growing substance abuse crisis, with an estimated 2.1 million Canadians aged 15 or older reporting illicit drug use in the past year. The prevalence of substance abuse is particularly concerning among certain demographics, such as youth, Indigenous populations, and individuals experiencing homelessness. The rising prevalence of substance abuse has significant implications for workplace safety, healthcare costs, and overall societal well-being. Drug screening testing plays a crucial role in identifying individuals struggling with substance abuse, enabling early intervention and treatment to prevent further harm. In industries where safety is paramount, such as transportation, construction, and healthcare, drug screening testing is often employed to mitigate the risk of accidents and injuries caused by substance impairment. Drug-impaired workers pose a significant threat to workplace safety, jeopardizing their own well-being and that of their colleagues. Drug screening testing can help identify individuals at risk of impairment, enabling preventive measures and appropriate interventions. Technological advancements in drug testing have enhanced the accuracy, convenience, and efficiency of drug screening methods. These advancements have led to the development of more sensitive testing kits, non-invasive testing procedures, and rapid on-site testing capabilities. Technological progress has also expanded the range of substances that can be detected through drug screening, enabling a more comprehensive assessment of potential substance use. These advancements contribute to the effectiveness of drug screening testing in identifying and addressing substance abuse concerns. Employers, healthcare providers, and the general public are becoming increasingly aware of the benefits of drug screening testing in various settings. As awareness grows, the demand for drug screening services is likely to increase.

According to the research report "Canada Drug Screening Market Overview, 2028," published by Bonafide Research, the Canada Drug Screening market is expected to add more than USD 250 Million from 2023 to 2028. Mobile drug testing solutions are becoming increasingly popular, particularly in remote locations or for large-scale testing events. These solutions offer flexibility and efficiency, allowing for on-site testing without the need for fixed testing facilities. Employers are using data analytics to gain insights from drug screening results, identifying trends and patterns that can inform workplace safety initiatives and employee support programs. Data-driven decision making helps employers tailor their drug screening programs to maximize effectiveness. With the legalization of recreational cannabis in Canada, there's a trend toward adapting drug testing policies to address the specific challenges posed by cannabis use. Employers may refine their testing protocols to distinguish between recreational use and impairment on the job. The availability and usage of at-home drug testing kits may be on the rise in Canada. These kits provide individuals with the convenience of self-administered tests, with samples sent to laboratories for analysis. Drug testing in sports organizations in Canada may evolve, with a focus on staying ahead of new performance-enhancing substances. The incorporation of advanced testing methods and broader panels reflects the commitment to maintaining fair play. The adoption of wearable technology for continuous monitoring of an individual's physiological indicators may be explored in Canada. This technology can provide real-time insights into substance use and potential impairment.

The Product and Service market is segmented into Consumables, Analytical Instruments, Rapid Testing Devices and Drug Screening Service. Drug screening services often provide comprehensive testing programs that cover a wide range of substances. This includes testing for common drugs of abuse as well as emerging substances, ensuring that organizations stay updated with the latest testing protocols and address evolving substance abuse trends. Drug screening services often provide comprehensive testing programs that cover a wide range of substances. This includes testing for common drugs of abuse as well as emerging substances, ensuring that organizations stay updated with the latest testing protocols and address evolving substance abuse trends. Drug screening services often offer customized solutions to meet the specific needs of different industries and organizations. Tailoring testing programs based on the unique requirements and risk profiles of clients contributes to the flexibility and effectiveness of these services. In addition based on end user, Laboratories that specialize in drug testing bring a high level of expertise to the market. These facilities often have experienced professionals, including toxicologists and laboratory technicians, who are well-versed in the complexities of drug testing methodologies. Laboratories typically offer a wide range of drug testing panels, covering various substances of abuse. This comprehensive approach allows them to cater to the diverse needs of different industries, including workplace testing, law enforcement, and healthcare. Leading laboratories invest in advanced testing technologies to enhance the accuracy and efficiency of drug testing. This may include the use of mass spectrometry, immunoassay techniques, and other advanced analytical methods that provide precise and reliable results. Laboratories typically provide medical review and interpretation of test results. This additional layer of expertise ensures that results are accurately analyzed, and any potential issues or anomalies are appropriately addressed. This is particularly important in contexts such as clinical drug testing.

Based on Sample Type the market is categorized into Urine Samples, Breath Samples, Hair Samples, Oral Fluid Samples and Other Samples. Urine drug testing has been a well-established and widely used method for decades. Its long history of use contributes to its familiarity, acceptance, and standardization in various industries, including workplace testing and healthcare. Urine testing is known for its relatively long detection window, allowing it to detect a wide range of drugs and their metabolites over an extended period. This feature is advantageous, especially in scenarios where historical drug use needs to be assessed. Urine testing is widely accepted and recognized in regulatory frameworks for workplace drug testing, forensic testing, and other contexts. The method aligns with established standards and guidelines, contributing to its regulatory acceptance. Collecting urine samples is a non-invasive process, making it practical and comfortable for individuals undergoing testing. This non-invasiveness contributes to the widespread acceptance of urine testing in various testing scenarios. Urine sample collection is a straightforward process that requires minimal training. This ease of collection is advantageous in workplace settings, where large-scale testing programs may be implemented, and samples need to be collected efficiently. Urine testing is often considered cost-effective compared to some alternative methods. The availability of cost-effective testing solutions and the ability to process multiple samples simultaneously contribute to its widespread use.

Considered in this report:
• Geography: Canada
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:
• Canada Drug Screening market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product and Service
• Consumables
• Analytical Instruments
• Rapid Testing Devices
• Drug Screening Service

By Sample Type
• Urine Samples
• Breath Samples
• Hair Samples
• Oral Fluid Samples
• Other Samples

By End User
• Laboratories
• Workplaces
• Hospitals
• Others

The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources.

Intended audience:
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Drug Screening industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.

ページTOPに戻る

Table of Contents